Skip to main content
Top
Published in: Obesity Surgery 1/2016

01-01-2016 | Review Article

The Impact of Bariatric Surgery on Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis

Authors: Daniel Skubleny, Noah J. Switzer, Richdeep S. Gill, Mark Dykstra, Xinzhe Shi, Margaret A. Sagle, Christopher de Gara, Daniel W. Birch, Shahzeer Karmali

Published in: Obesity Surgery | Issue 1/2016

Login to get access

Abstract

Bariatric surgery has been proven to be a successful management strategy for morbid obesity, but limited studies exist on its effect on polycystic ovary syndrome (PCOS). A comprehensive search of electronic databases was completed. Meta-analysis was performed on PCOS, hirsutism, and menstrual irregularity outcomes following bariatric surgery. Thirteen primary studies involving a total of 2130 female patients were identified. The incidence of PCOS preoperatively was 45.6 %, which significantly decreased to 6.8 % (P < 0.001) and 7.1 % (P < 0.0002) at 12-month follow-up and study endpoint, respectively. The incidences of preoperative menstrual irregularity and hirsutism both significantly decreased at 12-month and at study end follow-up. Bariatric surgery effectively attenuates PCOS and its clinical symptomatology including hirsutism and menstrual irregularity in severely obese women.
Literature
1.
go back to reference Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–81.PubMedPubMedCentralCrossRef Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–81.PubMedPubMedCentralCrossRef
2.
go back to reference Overweight, obesity, and health risk. Arch Intern Med. 2000;160(7): 898–904. Overweight, obesity, and health risk. Arch Intern Med. 2000;160(7): 898–904.
3.
go back to reference Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–7. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–7.
4.
go back to reference Trivax B, Azziz R. Diagnosis of polycystic ovary syndrome. Clin Obstet Gynecol. 2007;50(1):168–77.PubMedCrossRef Trivax B, Azziz R. Diagnosis of polycystic ovary syndrome. Clin Obstet Gynecol. 2007;50(1):168–77.PubMedCrossRef
5.
go back to reference Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):671–83.PubMedCrossRef Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):671–83.PubMedCrossRef
7.
go back to reference Hoeger KM, Oberfield SE. Do women with PCOS have a unique predisposition to obesity? Fertil Steril. 2012;97(1):13–7.PubMedCrossRef Hoeger KM, Oberfield SE. Do women with PCOS have a unique predisposition to obesity? Fertil Steril. 2012;97(1):13–7.PubMedCrossRef
8.
go back to reference Kiddy DS, Hamilton-Fairley D, Bush A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 1992;36(1):105–11.CrossRef Kiddy DS, Hamilton-Fairley D, Bush A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 1992;36(1):105–11.CrossRef
9.
go back to reference Domecq JP, Prutsky G, Mullan RJ, et al. Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis. J Clin Endocrinol Metab. 2013;98(12):4655–63.PubMedCrossRef Domecq JP, Prutsky G, Mullan RJ, et al. Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis. J Clin Endocrinol Metab. 2013;98(12):4655–63.PubMedCrossRef
10.
go back to reference Crosignani PG, Colombo M, Vegetti W, et al. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod. 2003;18(9):1928–32.PubMedCrossRef Crosignani PG, Colombo M, Vegetti W, et al. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod. 2003;18(9):1928–32.PubMedCrossRef
11.
go back to reference Eid GM, McCloskey C, Titchner R, et al. Changes in hormones and biomarkers in polycystic ovarian syndrome treated with gastric bypass. Surg Obes Relat Dis. 2014;10(5):787–91.PubMedCrossRef Eid GM, McCloskey C, Titchner R, et al. Changes in hormones and biomarkers in polycystic ovarian syndrome treated with gastric bypass. Surg Obes Relat Dis. 2014;10(5):787–91.PubMedCrossRef
12.
go back to reference Brancatisano A, Wahlroos S, Brancatisano R. Improvement in comorbid illness after placement of the Swedish adjustable gastric band. Surg Obes Relat Dis. 2008;4(3 Suppl):S39–46.PubMedCrossRef Brancatisano A, Wahlroos S, Brancatisano R. Improvement in comorbid illness after placement of the Swedish adjustable gastric band. Surg Obes Relat Dis. 2008;4(3 Suppl):S39–46.PubMedCrossRef
13.
go back to reference Collins J, Mattar S, Qureshi F, et al. Initial outcomes of laparoscopic Roux-en-Y gastric bypass in morbidly obese adolescents. Surg Obes Relat Dis. 2007;3(2):147–52.PubMedCrossRef Collins J, Mattar S, Qureshi F, et al. Initial outcomes of laparoscopic Roux-en-Y gastric bypass in morbidly obese adolescents. Surg Obes Relat Dis. 2007;3(2):147–52.PubMedCrossRef
14.
go back to reference Dixon JB, O'Brien PE. Neck circumference a good predictor of raised insulin and free androgen index in obese premenopausal women: changes with weight loss. Clin Endocrinol (Oxf). 2002;57(6):769–78.CrossRef Dixon JB, O'Brien PE. Neck circumference a good predictor of raised insulin and free androgen index in obese premenopausal women: changes with weight loss. Clin Endocrinol (Oxf). 2002;57(6):769–78.CrossRef
15.
go back to reference Eid GM, Cottam DR, Velcu LM, et al. Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2005;1(2):77–80.PubMedCrossRef Eid GM, Cottam DR, Velcu LM, et al. Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2005;1(2):77–80.PubMedCrossRef
16.
go back to reference Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, et al. The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab. 2005;90(12):6364–9.PubMedCrossRef Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, et al. The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab. 2005;90(12):6364–9.PubMedCrossRef
17.
go back to reference George K, Azeez H. Resolution of gynaecological issues after bariatric surgery—a retrospective analysis [abstract]. Obes Surg. 2013;23(8):1043. George K, Azeez H. Resolution of gynaecological issues after bariatric surgery—a retrospective analysis [abstract]. Obes Surg. 2013;23(8):1043.
18.
go back to reference Jamal M, Gunay Y, Capper A, et al. Roux-en-Y gastric bypass ameliorates polycystic ovary syndrome and dramatically improves conception rates: a 9-year analysis. Surg Obes Relat Dis. 2012;8(4):440–4.PubMedCrossRef Jamal M, Gunay Y, Capper A, et al. Roux-en-Y gastric bypass ameliorates polycystic ovary syndrome and dramatically improves conception rates: a 9-year analysis. Surg Obes Relat Dis. 2012;8(4):440–4.PubMedCrossRef
19.
go back to reference Kyriacou A, Hunter AL, Tolofari S, et al. Gastric bypass surgery in women with or without polycystic ovary syndrome—a comparative observational cohort analysis. Eur J Intern Med. 2014;25(2):e23–4.PubMedCrossRef Kyriacou A, Hunter AL, Tolofari S, et al. Gastric bypass surgery in women with or without polycystic ovary syndrome—a comparative observational cohort analysis. Eur J Intern Med. 2014;25(2):e23–4.PubMedCrossRef
20.
go back to reference Luk S, Wong S, Ng E. Bariatric surgery in Chinese patients with polycystic ovarian syndrome (PCOS) [abstract]. Obes Surg. 2014;24(8):1168. Luk S, Wong S, Ng E. Bariatric surgery in Chinese patients with polycystic ovarian syndrome (PCOS) [abstract]. Obes Surg. 2014;24(8):1168.
21.
go back to reference Messiah SE, Lopez-Mitnik G, Winegar D, et al. Changes in weight and co-morbidities among adolescents undergoing bariatric surgery: 1-year results from the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2013;9(4):503–13.PubMedPubMedCentralCrossRef Messiah SE, Lopez-Mitnik G, Winegar D, et al. Changes in weight and co-morbidities among adolescents undergoing bariatric surgery: 1-year results from the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2013;9(4):503–13.PubMedPubMedCentralCrossRef
22.
go back to reference Sugerman HJ, Sugerman EL, DeMaria EJ, et al. Bariatric surgery for severely obese adolescents. J Gastrointest Surg. 2003;7(1):102–7. discussion 107–8.PubMedCrossRef Sugerman HJ, Sugerman EL, DeMaria EJ, et al. Bariatric surgery for severely obese adolescents. J Gastrointest Surg. 2003;7(1):102–7. discussion 107–8.PubMedCrossRef
23.
go back to reference Talebpour M. Role of excessive weight loss in treatment of infertility and irregular periodic cycle in morbid obese female secondary to bariatric surgery [abstract]. Obes Surg. 2011;21(8):1119. Talebpour M. Role of excessive weight loss in treatment of infertility and irregular periodic cycle in morbid obese female secondary to bariatric surgery [abstract]. Obes Surg. 2011;21(8):1119.
24.
go back to reference Moran LJ, Misso ML, Wild RA, et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347–63.PubMedCrossRef Moran LJ, Misso ML, Wild RA, et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347–63.PubMedCrossRef
25.
go back to reference Chittenden BG, Fullerton G, Maheshwari A, et al. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online. 2009;19(3):398–405.PubMedCrossRef Chittenden BG, Fullerton G, Maheshwari A, et al. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online. 2009;19(3):398–405.PubMedCrossRef
26.
go back to reference de Groot PC, Dekkers OM, Romijn JA, et al. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update. 2011;17(4):495–500.PubMedCrossRef de Groot PC, Dekkers OM, Romijn JA, et al. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update. 2011;17(4):495–500.PubMedCrossRef
27.
go back to reference Kiddy DS, Sharp PS, White DM, et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol (Oxf). 1990;32(2):213–20.CrossRef Kiddy DS, Sharp PS, White DM, et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol (Oxf). 1990;32(2):213–20.CrossRef
28.
go back to reference Hoeger K. Obesity and weight loss in polycystic ovary syndrome. Obstet Gynecol Clin N Am. 2001;28(1):85–97. vi-vii.CrossRef Hoeger K. Obesity and weight loss in polycystic ovary syndrome. Obstet Gynecol Clin N Am. 2001;28(1):85–97. vi-vii.CrossRef
29.
go back to reference Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006;113(10):1148–59.PubMedCrossRef Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006;113(10):1148–59.PubMedCrossRef
30.
go back to reference Lim SS, Norman RJ, Davies MJ, et al. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev. 2013;14(2):95–109.PubMedCrossRef Lim SS, Norman RJ, Davies MJ, et al. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev. 2013;14(2):95–109.PubMedCrossRef
31.
go back to reference Fogel RB, Malhotra A, Pillar G, et al. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86(3):1175–80.PubMed Fogel RB, Malhotra A, Pillar G, et al. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86(3):1175–80.PubMed
32.
go back to reference Sam S, Dunaif A. Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab. 2003;14(8):365–70.PubMedCrossRef Sam S, Dunaif A. Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab. 2003;14(8):365–70.PubMedCrossRef
33.
go back to reference Dunaif A, Segal KR, Futterweit W, et al. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38(9):1165–74.PubMedCrossRef Dunaif A, Segal KR, Futterweit W, et al. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38(9):1165–74.PubMedCrossRef
34.
go back to reference Dunaif A, Segal KR, Shelley DR, et al. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes. 1992;41(10):1257–66.PubMedCrossRef Dunaif A, Segal KR, Shelley DR, et al. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes. 1992;41(10):1257–66.PubMedCrossRef
35.
go back to reference Pantasri T, Norman RJ. The effects of being overweight and obese on female reproduction: a review. Gynecol Endocrinol. 2014;30(2):90–4.PubMedCrossRef Pantasri T, Norman RJ. The effects of being overweight and obese on female reproduction: a review. Gynecol Endocrinol. 2014;30(2):90–4.PubMedCrossRef
36.
go back to reference Poretsky L, Cataldo NA, Rosenwaks Z, et al. The insulin-related ovarian regulatory system in health and disease. Endocr Rev. 1999;20(4):535–82.PubMedCrossRef Poretsky L, Cataldo NA, Rosenwaks Z, et al. The insulin-related ovarian regulatory system in health and disease. Endocr Rev. 1999;20(4):535–82.PubMedCrossRef
37.
go back to reference Chou SH, Mantzoros C. 20 years of leptin: role of leptin in human reproductive disorders. J Endocrinol. 2014;223(1):T49–62.PubMedCrossRef Chou SH, Mantzoros C. 20 years of leptin: role of leptin in human reproductive disorders. J Endocrinol. 2014;223(1):T49–62.PubMedCrossRef
38.
go back to reference Yildizhan R, Ilhan GA, Yildizhan B, et al. Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome. Fertil Steril. 2011;96(1):246–50.PubMedCrossRef Yildizhan R, Ilhan GA, Yildizhan B, et al. Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome. Fertil Steril. 2011;96(1):246–50.PubMedCrossRef
39.
go back to reference Mitchell M, Armstrong DT, Robker RL, et al. Adipokines: implications for female fertility and obesity. Reproduction. 2005;130(5):583–97.PubMedCrossRef Mitchell M, Armstrong DT, Robker RL, et al. Adipokines: implications for female fertility and obesity. Reproduction. 2005;130(5):583–97.PubMedCrossRef
40.
go back to reference Hollmann M, Runnebaum B, Gerhard I. Effects of weight loss on the hormonal profile in obese, infertile women. Hum Reprod. 1996;11(9):1884–91.PubMedCrossRef Hollmann M, Runnebaum B, Gerhard I. Effects of weight loss on the hormonal profile in obese, infertile women. Hum Reprod. 1996;11(9):1884–91.PubMedCrossRef
41.
go back to reference Kowalska I, Kinalski M, Straczkowski M, et al. Insulin, leptin, IGF-I and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome. Eur J Endocrinol. 2001;144(5):509–15.PubMedCrossRef Kowalska I, Kinalski M, Straczkowski M, et al. Insulin, leptin, IGF-I and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome. Eur J Endocrinol. 2001;144(5):509–15.PubMedCrossRef
42.
go back to reference Anderson JW, Konz EC, Frederich RC, et al. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 2001;74(5):579–84.PubMed Anderson JW, Konz EC, Frederich RC, et al. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 2001;74(5):579–84.PubMed
43.
go back to reference Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142(7):547–59.PubMedCrossRef Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142(7):547–59.PubMedCrossRef
44.
Metadata
Title
The Impact of Bariatric Surgery on Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis
Authors
Daniel Skubleny
Noah J. Switzer
Richdeep S. Gill
Mark Dykstra
Xinzhe Shi
Margaret A. Sagle
Christopher de Gara
Daniel W. Birch
Shahzeer Karmali
Publication date
01-01-2016
Publisher
Springer US
Published in
Obesity Surgery / Issue 1/2016
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-015-1902-5

Other articles of this Issue 1/2016

Obesity Surgery 1/2016 Go to the issue